Literature DB >> 29250282

Use of Oral Steroid and its Effects on Atrial Fibrillation Recurrence and Inflammatory Cytokines Post Ablation - The Steroid AF Study.

Sandia Iskandar1, Madhu Reddy1, Muhammad R Afzal1, Johnson Rajasingh1, Moustapha Atoui1, Madhav Lavu1, Donita Atkins1, Sudha Bommana1, Linda Umbarger1, Misty Jaeger1, Rhea Pimentel1, Raghuveer Dendi1, Martin Emert1, Mohit Turagam2, Luigi Di Biase3, Andrea Natale4, Dhanunjaya Lakkireddy1.   

Abstract

BACKGROUND: Use of corticosteroids before and after atrial fibrillation (AF) ablation can decrease acute inflammation and reduce AF recurrence.
PURPOSE: To assess the efficacy of oral prednisone in improving the outcomes of pulmonary vein isolation with radiofrequency ablation and its effect on inflammatory cytokine.
METHODS: A total of 60 patients with paroxysmal AF undergoing radiofrequency ablation were randomized (1:1) to receive either 3 doses of 60 mg daily of oral prednisone or a placebo. Inflammatory cytokine levels (TNF-α, IL-1, IL6, IL-8) were measured at baseline, prior to ablation, immediately after ablation, and 24 hours post ablation. Patients underwent 30 day event monitoring at 3 months, 6 months and 12 months post procedure.
RESULTS: Immediate post ablation levels of inflammatory cytokines were lower in the steroid group when compared to the placebo group; IL-6: 9.0 ±7 vs 15.8 ±13 p=0.031; IL-8: 10.5 ±9 vs 15.3 ±8; p=0.047 respectively. Acute PV reconnection rates during the procedure (7/23% vs 10/36%; p = 0.39), and RF ablation time (51±13 vs 56±11 min, p = 0.11) trended to be lower in the placebo group than the steroid group. There was no difference in the incidence of early recurrence of AF during the blanking period and freedom from AF off AAD at 12 months between both groups (5/17% vs 8/27%; p = 0.347 and 21/70% vs 18/60%; p=0.417 in placebo and steroid groups respectively).
CONCLUSION: Although oral corticosteroids have significant effect in lowering certain cytokines, it did not impact the clinical outcomes of AF ablation.

Entities:  

Keywords:  Ablation; Atrial Fibrillation; Corticosteroid; Inflammatory cytokines; Interleukin; Prednisone; Pulmonary Vein Isolation; Recurrence; Tumor Necrosis Factor

Year:  2017        PMID: 29250282      PMCID: PMC5673398          DOI: 10.4022/jafib.1604

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  25 in total

1.  Corticosteroid therapy after catheter ablation of atrial fibrillation for an authentic "blanking period".

Authors:  Bernard Belhassen
Journal:  J Am Coll Cardiol       Date:  2010-10-26       Impact factor: 24.094

2.  Glucocorticoid use and risk of atrial fibrillation or flutter: a population-based, case-control study.

Authors:  Christian Fynbo Christiansen; Steffen Christensen; Frank Mehnert; Steven R Cummings; Roland D Chapurlat; Henrik Toft Sørensen
Journal:  Arch Intern Med       Date:  2009-10-12

3.  Pulmonary vein isolation for atrial fibrillation: forever young.

Authors:  Pasquale Santangeli; Francis E Marchlinski
Journal:  J Am Coll Cardiol       Date:  2014-12-16       Impact factor: 24.094

4.  Corticosteroids and the risk of atrial fibrillation.

Authors:  Cornelis S van der Hooft; Jan Heeringa; Guy G Brusselle; Albert Hofman; Jacqueline C M Witteman; J Herre Kingma; Miriam C J M Sturkenboom; Bruno H Ch Stricker
Journal:  Arch Intern Med       Date:  2006-05-08

5.  Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci.

Authors:  M Haïssaguerre; P Jaïs; D C Shah; S Garrigue; A Takahashi; T Lavergne; M Hocini; J T Peng; R Roudaut; J Clémenty
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

6.  Impact of prophylactic corticosteroids on systemic inflammation after extensive atrial ablation in pigs.

Authors:  Thais Nascimento; Fernanda Mota; Luis Felipe dos Santos; Sérgio de Araujo; Mieko Okada; Marcello Franco; Angelo de Paola; Guilherme Fenelon
Journal:  Europace       Date:  2011-08-15       Impact factor: 5.214

7.  Mechanisms by which adenosine restores conduction in dormant canine pulmonary veins.

Authors:  Tomás Datino; Laurent Macle; Xiao-Yan Qi; Ange Maguy; Philippe Comtois; Denis Chartier; Peter G Guerra; Angel Arenal; Francisco Fernández-Avilés; Stanley Nattel
Journal:  Circulation       Date:  2010-02-16       Impact factor: 29.690

8.  Efficacy and safety of targeted focal ablation versus PV isolation assisted by magnetic electroanatomic mapping.

Authors:  Francis E Marchlinski; David Callans; Sanjay Dixit; Edward P Gerstenfeld; Robert Rho; Jian-Fang Ren; Erica Zado
Journal:  J Cardiovasc Electrophysiol       Date:  2003-04

9.  Protracted CRP elevation after atrial fibrillation ablation.

Authors:  James M McCabe; Lisa M Smith; Zian H Tseng; Nitish Badhwar; Byron K Lee; Randall J Lee; Melvin M Scheinman; Jeffrey E Olgin; Gregory M Marcus
Journal:  Pacing Clin Electrophysiol       Date:  2008-09       Impact factor: 1.976

10.  [Effects of hydrocortisone sodium succinate on sodium current in human and guinea pig cardiac myocytes].

Authors:  Zhuang-li Hu; Hui Liu; Yan Hu; De-yong Zhang; Zong-quan Sun; Man-wen Jin
Journal:  Yao Xue Xue Bao       Date:  2004-04
View more
  8 in total

Review 1.  Inflammasomes and Proteostasis Novel Molecular Mechanisms Associated With Atrial Fibrillation.

Authors:  Na Li; Bianca J J M Brundel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

2.  Early Recurrences During the Blanking Period after Atrial Fibrillation Ablation.

Authors:  Jackson J Liang; Sanjay Dixit
Journal:  J Atr Fibrillation       Date:  2018-02-28

3.  Atrial fibrillation.

Authors: 
Journal:  Nat Rev Dis Primers       Date:  2016-03-31       Impact factor: 65.038

4.  Simple hematological predictors of AF recurrence in patients undergoing atrial fibrillation ablation.

Authors:  George Bazoukis; Konstantinos P Letsas; Konstantinos Vlachos; Athanasios Saplaouras; Dimitrios Asvestas; Konstantinos Tyrovolas; Aikaterini Rokiza; Eirini Pagkalidou; Gary Tse; Stavros Stavrakis; Antonios Sideris; Michael Efremidis
Journal:  J Geriatr Cardiol       Date:  2019-09       Impact factor: 3.327

Review 5.  Role of inflammation in atrial fibrillation: A comprehensive review of current knowledge.

Authors:  Nso Nso; Kaveh R Bookani; Mark Metzl; Farshid Radparvar
Journal:  J Arrhythm       Date:  2020-12-23

Review 6.  Evidence for Inflammation as a Driver of Atrial Fibrillation.

Authors:  Xiaoxu Zhou; Samuel C Dudley
Journal:  Front Cardiovasc Med       Date:  2020-04-29

7.  Inflammation, atrial fibrillation, and the potential role for colchicine therapy.

Authors:  Bibin Varghese; David I Feldman; Christopher Chew; Eva Valilis; Roger S Blumenthal; Garima Sharma; Hugh Calkins
Journal:  Heart Rhythm O2       Date:  2021-04-02

Review 8.  New aspects of endocrine control of atrial fibrillation and possibilities for clinical translation.

Authors:  Martin Aguilar; Robert A Rose; Abhijit Takawale; Stanley Nattel; Svetlana Reilly
Journal:  Cardiovasc Res       Date:  2021-06-16       Impact factor: 10.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.